SHANGHAI, NANJING, China and SAN JOSE, Calif., March 28, 2025 /PRNewswire/ -- IASO Biotherapeutics ("IASO Bio"), a biopharmaceutical company focused on the discovery, development, manufacturing, and commercialization of innovative cell therapies and biologics, today announced that the...
Hence then, the article about iaso bio announces approval of new drug application for equecabtagene autoleucel by the macau pharmaceutical administration bureau was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( IASO Bio Announces Approval of New Drug Application for Equecabtagene Autoleucel by the Macau Pharmaceutical Administration Bureau )
Also on site :
- Skanska signs additional contract with existing client to build a data center in USA for USD 228M, about SEK 2.2 billion
- ‘No way out’: Telangana student dies in Germany after jumping from burning apartment on New Year’s Eve
- HEA vs STA Dream11 Prediction, Dream11 Playing XI, Today Match 20, Big Bash League 2025-26